Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11, 1374

Vaccines (Aug 2024)

Affiliations

Tjalf Ziemssen: Department of Neurology, Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, University Hospital of Dresden, Technische Universität Dresden, 01307 Dresden, Germany
Marie Groth: Novartis Pharma GmbH, 90429 Nuremberg, Germany
Veronika Eva Winkelmann: Novartis Pharma GmbH, 90429 Nuremberg, Germany
Tobias Bopp: Institute for Immunology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany

Abstract

The authors would like to make the following corrections to this published paper [...]